|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by HC Wainwright & Co. on November 24, 2021. The analyst firm set a price target for 26.00 expecting OCUP to rise to within 12 months (a possible 497.70% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $4.35 last updated Fri Nov 26 2021 18:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Ocuphire Pharma.
Ocuphire Pharma’s $Q3 earnings are confirmed for after-market on November 12, 2021.
There is no upcoming split for Ocuphire Pharma.
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.